Influence of Staphylococcus aureus Strain Background on Sa3int Phage Life Cycle Switches

Viruses. 2022 Nov 8;14(11):2471. doi: 10.3390/v14112471.

Abstract

Staphylococcus aureus asymptomatically colonizes the nasal cavity of mammals, but it is also a leading cause of life-threatening infections. Most human nasal isolates carry Sa3 phages, which integrate into the bacterial hlb gene encoding a sphingomyelinase. The virulence factor-encoding genes carried by the Sa3-phages are highly human-specific, and most animal strains are Sa3 negative. Thus, both insertion and excision of the prophage could potentially confer a fitness advantage to S. aureus. Here, we analyzed the phage life cycle of two Sa3 phages, Φ13 and ΦN315, in different phage-cured S. aureus strains. Based on phage transfer experiments, strains could be classified into low (8325-4, SH1000, and USA300c) and high (MW2c and Newman-c) transfer strains. High-transfer strains promoted the replication of phages, whereas phage adsorption, integration, excision, or recA transcription was not significantly different between strains. RNASeq analyses of replication-deficient lysogens revealed no strain-specific differences in the CI/Mor regulatory switch. However, lytic genes were significantly upregulated in the high transfer strain MW2c Φ13 compared to strain 8325-4 Φ13. By transcriptional start site prediction, new promoter regions within the lytic modules were identified, which are likely targeted by specific host factors. Such host-phage interaction probably accounts for the strain-specific differences in phage replication and transfer frequency. Thus, the genetic makeup of the host strains may determine the rate of phage mobilization, a feature that might impact the speed at which certain strains can achieve host adaptation.

Keywords: Staphylococcus; gene regulation; hemolysin; induction; phage; virulence.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bacterial Toxins* / genetics
  • Bacterial Toxins* / metabolism
  • Humans
  • Life Cycle Stages
  • Mammals
  • Staphylococcal Infections* / microbiology
  • Staphylococcus Phages / genetics
  • Staphylococcus Phages / metabolism
  • Staphylococcus aureus

Substances

  • Bacterial Toxins

Grants and funding

This work was funded by Deutsche Forschungsgemeinschaft, GRK1708 to CW and CR (Project 174858087), Schwerpunktprogramm Spp2330 to CW (Project 464612409), and by infrastructural funding from the Deutsche Forschungsgemeinschaft (DFG), Cluster of Excellence EXC 2124 “Controlling Microbes to Fight Infections” (Project 390838134).